21 reports

  • HPV TESTING MARKET IN AMERICAS
  • DEVELOPMENT OF MRNA HPV TEST

Roche Diagnostics opportunity assessment OPPORTUNITY ASSESSMENT Qiagen is one of the global leaders in HPV testing.

  • HPV Testing
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • Diagnostics
  • HPV Testing
  • Demand
  • Forecast
  • Market Size
  • Device Type
  • SWOT Analysis of Abbott in the HPV & EBV Tests, 2017

Table ##: North America HPV & EBV Tests Volume Forecast, 2015-2024 (in thousands) Table ##: Europe HPV & EBV Tests Volume Forecast, 2015-2024 (in thousands) HPV Tests ## ## ## ## ## ## ## ##, ## ##, ## ##, ## ##. ##% EBV Tests ## ##

  • HPV Testing
  • Sexually Transmitted Disease
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group
  • 6.4.2 HPV TEST MARKET
  • 5.4.2 HPV TEST VOLUME

Around ##. ## Million HPV test have completed in China in 2016.

  • Diagnostics
  • HPV Testing
  • China
  • East Asia
  • OriGene Technologies, Inc.

Hoffmann-La Roche Ltd. ##. ## Fujirebio Diagnostics, Inc. ##. ## Hologic, Inc. ##. ## OncoHealth Corporation ##. ## QIAGEN N. V List of Figures FIG. ## Global Cytology and HPV Testing Market Estimates and Forecast, (US$ Mn), 2014–2024 FIG. ## Global HPV Testing Market

  • Diagnostics
  • HPV Testing
  • World
  • Market Size

2016 Future Horizons and Growth Strategies in the Global Pap Smear/ HPV Testing Market: Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/ HPV Tests Franc

  • Diagnostics
  • HPV Testing
  • Demand

Europe Pap Smear/ HPV Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts Europe Pap Smear/ HPV Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segmen

  • HPV Testing
  • Europe
  • France
  • Germany
  • Forecast

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • Diagnostics
  • HPV Testing
  • Europe
  • France
  • Forecast

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • HPV Testing
  • Europe
  • France
  • Germany
  • Forecast

This report presents a detailed analysis of the Pap Smear/ HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segm

  • HPV Testing
  • Europe
  • France
  • Germany
  • Forecast
  • ATTOSENSE HPV TEST - PRODUCT STATUS
  • ATTOSENSE HPV TEST - PRODUCT DESCRIPTION

HPV TEST SALES.

  • Clinical Trial
  • DNA
  • HPV Testing
  • Sexually Transmitted Disease
  • ValiRx Plc

2016 World Pap Smear/ HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe, Japan (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/ HPV

  • Diagnostics
  • HPV Testing
  • Japan
  • United States
  • Demand

2016 Europe Pap Smear/ HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/

  • HPV Testing
  • France
  • Germany
  • Italy
  • Demand

Distribution Strategies ##.

  • HPV Testing
  • Europe
  • France
  • Germany
  • Demand

Distribution Strategies ##.

  • HPV Testing
  • Europe
  • France
  • Germany
  • Demand
  • HPV test
  • 6.5 PRIMARY HPV TESTING

The Aptima HPV test is one of the leading products in the HPV testing market.

  • Diagnostics
  • Healthcare
  • Hospital
  • HPV Testing
  • Laboratory
  • JUN 21, 2016: GENERA BIOSYSTEMS PROVIDES UPDATE ON PAPTYPE HPV TEST
  • MAY 01, 2017: GENERA BIOSYSTEMS: QUARTERLY CASH FLOW & BUSINESS UPDATE FOR THE PERIOD ENDED 31 MARCH 2017

PAPTYPE® IS ONE OF ONLY A FEW COMMERCIALLY AVAILABLE CE MARKED HPV TESTS THAT SIMULTANEOUSLY DETECTS AND GENOTYPES ALL ## CARCINOGENIC STRAINS OF HPV.

  • HPV Testing
  • Australia
  • India
  • Company Financials
  • Genera Biosystems Limited

MARKET ##.

  • Diagnostics
  • HPV Testing
  • World
  • Company Financials
  • May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017
  • Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update

Meijer compliant data will support the market positioning of Genera' s PapType®HPV test when the new cervical screening regime is introduced in the Australian market on ## December 2017.

  • Diagnostics
  • HPV Testing
  • Australia
  • Company Financials
  • Genera Biosystems Limited
  • May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017
  • Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update

Meijer compliant data will support the market positioning of Genera' s PapType®HPV test when the new cervical screening regime is introduced in the Australian market on ## December 2017.

  • HPV Testing
  • Molecular Diagnostics
  • Australia
  • Company Financials
  • Genera Biosystems Limited
  • ATTOSENSE HPV TEST - PRODUCT DESCRIPTION
  • ATTOSENSE HPV TEST - PRODUCT STATUS

CLINICALLY VALIDATED BY THE LANDMARK ATHENA TRIAL, THE COBAS HPV TEST PROVIDES SPECIFIC GENOTYPING INFORMATION FOR HPV ## AND HPV ##, THE HIGHEST-RISK TYPES, WHILE SIMULTANEOUSLY REPORTING THE ## OTHER HIGH-RISK HPV TYPES AS A POOLED RESULT, ALL IN

  • Clinical Trial
  • Genome Sequencing
  • HPV Testing
  • Sexually Transmitted Disease
  • Roche Group